Skip to main content
Frontiers in Psychiatry logoLink to Frontiers in Psychiatry
. 2020 Feb 7;11:27. doi: 10.3389/fpsyt.2020.00027

Mapping Theme Trends and Knowledge Structure of Magnetic Resonance Imaging Studies of Schizophrenia: A Bibliometric Analysis From 2004 to 2018

Li Duan 1, Gang Zhu 1,2,*
PMCID: PMC7019376  PMID: 32116844

Abstract

Background

Recently, magnetic resonance imaging (MRI) technology has been widely used to quantitatively analyze brain structure, morphology, and functional activities, as well as to clarify the neuropathological and neurobiological mechanisms of schizophrenia. However, although there have been many relevant results and conclusions, there has been no systematic assessment of this field.

Aim

To analyze important areas of research utilizing MRI in studies of schizophrenia and explore major trends and the knowledge structure using bibliometric analysis.

Methods

Literature related to MRI studies of schizophrenia published in PubMed between January 1, 2004 and December 31, 2018 were retrieved in 5-year increments. The extracted major Medical Subject Headings (MeSH) terms/MeSH subheadings were analyzed quantitatively. Bi-clu-stering analysis, social network analysis (SNA), and strategic diagrams were employed to analyze the word matrix and co-occurrence matrix of high-frequency MeSH terms.

Results

For the periods of 2004 to 2008, 2009 to 2013, and 2014 to 2018, the number of relevant retrieved publications were 916, 1,344, and 1,512 respectively, showing an overall growth trend. 26, 34, and 36 high-frequency major MeSH terms/MeSH subheadings were extracted in each period, respectively. In line with strategic diagrams, the main undeveloped theme clusters in 2004–2008 were effects of antipsychotics on brain structure and their curative efficacy. These themes were replaced in 2009–2013 by physiopathology mechanisms of schizophrenia, etiology of cognitive disorder, research on default mode network and schizophrenic psychology, and were partially replaced in 2014–2018 by studies of differences in the neurobiological basis for schizophrenia and other mental disorders. Based on SNA, nerve net/physiopathology and psychotic disorder/pathology were considered the emerging hotspots of research in 2009–2013 and 2014–2018.

Conclusions

MRI studies on schizophrenia were relatively diverse, but the theme clusters derived from each period may reflect the publication trends to some extent. Bibliometric research over a 15-year period may be helpful in depicting the overall scope of research interest and may generate novel ideas for researchers initiating new projects.

Keywords: schizophrenia, magnetic resonance imaging, bibliometric analysis, co-occurrence analysis, social network analysis, strategic diagram

Introduction

Schizophrenia, as a common and devastating mental disorder, has been characterized by abnormal social behavior and the failure to understand reality, accompanied by emotional disorder or substance abuse, and even suicide (approximately 5%) (1), which leads to high risk for physical diseases, increased disability and recurrence for patients, and places a serious burden on their families and society (2, 3). The prevalence of schizophrenia has been stable at around 1% (4), and the years lived with disability (YLD) due to schizophrenia in 2016 was estimated to be 13.4 million years [95% uncertainty interval (UI), 9.9–16.7 million years], accounting for 1.7% of all YLDs and ranking 15th among all diseases worldwide (5). Nevertheless, the underlying etiology and pathogenesis of schizophrenia have not been fully elucidated, but scholars have come to the consensus that it is a disabling encephalopathy caused by a group of genetic factors, as well as heterogeneous neurodevelopmental risk factors and adverse environmental stimuli (69).

At present, clinical diagnosis of schizophrenia is mainly based on patients’ abnormal behavior. Clinical symptoms are described with quantitative dimensions, such as the quantitative evaluation of symptoms with the Positive and Negative Syndrome Scale (10). However, when patients exhibit typical psychotic symptoms and abnormal behaviors, they usually have advanced or relapsed into the middle and late stages of schizophrenia, which is not conducive to the implementation of rapid and effective treatment programs and the long-term recovery of patients. In recent years, neuroimaging technology has become an important way to understand normal physiological functions and pathological phenomena in the brain. Although patients with schizophrenia usually have anomalous brain structure and function, as well as neurological damage, it is possible for psychiatrists to explore early diagnosis, screen for specific biomarkers, monitor pathogenetic progression and therapeutic efficacy, and uncover pathophysiological mechanisms by employing structural and functional imaging technologies (1115). Magnetic resonance imaging (MRI) scanning techniques focus primarily on structural magnetic resonance imaging, resting-state functional magnetic resonance imaging and diffuse tensor imaging (DTI). As early as 1927, scientists began to perform brain scans of schizophrenia patients, but the traumatic operation (injecting air into the cerebrospinal canal) meant that patients had to endure pain for months (16). It wasn’t until 1976 that Johnstone used computerized tomography technology to make the first non-invasive study of the brain of schizophrenia patients with enlarged lateral ventricles (17). Later, to improve the poor discrimination of soft tissue, Smith et al. conducted the first MRI study on schizophrenia patients in 1984 (18). Depending on the characteristics of the various imaging diagnostic techniques employed, the scope of MRI applications may differ; for example, structural magnetic resonance imaging (sMRI) enables high resolution spatial imaging of the brain in vivo based on its unique advantages which provide noninvasive, harmless and high spatial resolution, while DTI allows observation of the direction and structural integrity of nerve fiber bundles in the white matter in vivo, and functional MRI (fMRI) can detect functional activity of the brain. Furthermore, with the development of magnetic resonance technology, researchers are gradually extending their exploration of the brain of patients with schizophrenia and achieving fruitful results to better carry out clinical work and provide more professional advice for patients.

Bibliometrics, as a branch of library and information science, originated in the early 20th century. It is a comprehensive application of mathematics and statistics to conduct quantitative analysis and description of various characteristics of published literatures, so as to provide an easy method to evaluate research status and predict the developmental trends (19). Therefore, bibliometric analysis, including co-citation analysis, co-word analysis, and other methods, can help researchers grasp the changing trends of a given research field (20). While these methods have enriched the research content of MRI studies on schizophrenia, at present, few studies have attempted to focus on and sort out the important issues and research context from the perspective of bibliometrics. In view of this situation, this study attempted to analyze and summarize the internal and external characteristics of related literatures and track and intuitively display the research trends and frontiers in the field of MRI studies on schizophrenia by the integrated application of co-word analysis, bi-clustering analysis, strategic diagram, and social network analysis (SNA). Our goal is to promote public knowledge and provide reference for the increasing depth and breadth of future research on schizophrenia.

Methods

Data Collection, Data Extraction, and Bibliographic Matrix Setup

Literature involved in this study were retrieved and downloaded from the PubMed database(National Center for Biotechnology Information, U.S. National Library of Medicine, Rockville Pike, Bethesda MD, USA). Medical Subject Headings (MeSH) which are characterized by accuracy (accurately revealing the subject of the literature) and specificity can be used to index and catalog literatures in PubMed. In this study, the retrieval model was set as [“Magnetic Resonance Imaging”(Mesh) OR “Diffusion Tensor Imaging”(Mesh) OR “Diffusion Tensor Imaging”(Title/Abstract) AND “Schizophrenia”(Mesh)] with the filter restriction of literature type as “journal article” and language as “English”. In addition, in order to dynamically analyze the changes in hotspots, theme trends and knowledge structure of related studies of MRI and schizophrenia, the publication scope was divided into three periods (January 1, 2004 to December 31, 2008, January 1, 2009 to December 31, 2013, and January 1, 2014 to December 31, 2018). Finally, 916, 1,344, and 1,512 related literatures were retrieved in each period, respectively. Additionally, two researchers are required to carry out the primary retrieval and literature screening based on reviewing titles, abstracts, as well as full text in some cases independently.

Bibliographic information, including publication dates, countries, titles, authors, journal categories, major MeSH terms, MeSH subheading terms, abstracts, and other related characteristics of these literatures were accurately extracted and properly kept in XML format. The principle of h-index (21) was followed to set the threshold value of the high- and low-frequency major MeSH terms/MeSH subheadings. As a hybrid quantitative index, it was originally proposed by Hirsch to quantify the output of an individual researcher and gradually expand the index to evaluate the influence of patents (22), academic journals (23), research institutions (24), and so on. In this study, the Bibliographic Item Co-occurrence Matrix Builder (BICOMB) (25) was applied to read and analyze the bibliographic information of these retrieved literatures. Word frequency statistics in descending order were obtained with “major MeSH terms/MeSH subheadings.” When the word frequency was consistent with its rank, all major MeSH terms/MeSH subheadings greater than or equal to the rank were considered high frequency. Thereafter, fundamental data from the term-source literature and the term-term co-occurrence matrix were also generated to prepare for the subsequent bibliometric analysis.

Bi-Clustering Analysis of High-Frequency Mesh Terms

Bi-clustering analysis, also known as two-way clustering, was first proposed by Hartigan in 1972 (26). It refers to the concurrent clustering of rows and columns of data, and the simultaneous application of objects and their attributes to extract their common information. In this study, bi-clustering analysis of high-frequency major MeSH terms/MeSH subheadings was conducted on the basis of the term-source literature matrix by employing gCLUTO (Graphical Clustering Toolkit) software (http://glaros.dtc.umn.edu/gkhome/cluto/gcluto/download), with the aim of assessing the knowledge structure of studies on MRI of schizophrenia. The results are presented in the form of a visual matrix and visual mountain.

The two-dimensional matrix visualization, as a colorful interactive matrix, is composed of horizontal rows of high-frequency major MeSH terms/MeSH subheadings and vertical columns of PubMed unique identifiers (PMID) of these retrieved literatures, which are showed on the left and the top of the matrix, respectively. Mountain visualization attempts to describe the relationship between clusters from a three-dimensional perspective, and we can estimate the relative similarity between peaks by estimating the distance between them. The volume and height of each mountain is proportional to the number of high-frequency MeSH terms contained in a cluster and their similarity within the cluster, respectively. The greater the similarity within a cluster, the steeper the mountain. In addition, the colors of peaks include red, yellow, light blue, and dark blue. Red represents a lower standard deviation of the internal similarity in the cluster, while blue denotes a higher standard deviation. In addition, the closer the color is to a single color, the smaller is the deviation between the internal MeSH terms of various clusters and the greater is their similarity.

Furthermore, according to calculate statistical indices, including descriptive (literatures that represents this class of characteristics) and discriminating (literatures that distinguishes it from other clusters) of each high-frequency major MeSH terms/MeSH subheadings to the clusters, trace back to the source literatures by identifying the PMID that contributes the most to the formation of each cluster as the significant representative literatures. These extracted representative literatures can be used to summarize and interpret content of the theme cluster.

Strategic Diagram Analysis

The analysis method of strategic diagram was first proposed by Law et al. in 1988 and aimed to describe the complex internal structure and developmental trend of hotspots in a research field on the basis of the co-occurrence matrix and bi-cluster analysis (27). The two-dimensional strategic diagram (28), formed by employing software of GraphPad Prism 5.0 (Graphpad, Inc., La Jolla, CA, USA), places on the horizontal axis centrality or degree of external cohesion, namely, the central position of the theme cluster with other clusters. The vertical axis specifies the density or degree of internal cohesion, namely, the conceptual development of the theme cluster.

The strategic diagram can be divided into four quadrants moving counterclockwise (Figure 5A). The theme cluster which is located in the first quadrant (Quadrant I, upper right), represents the development core and relatively mature hotspots in the field, implying strong centrality, and high density. Theme clusters in the second quadrant (Quadrant II, upper left) are characterized by inadequate external interactions, but high density of terms in periphery development in this research field. The third quadrant (Quadrant III, lower left) consists of theme clusters with weak centrality and low density, which are identified as emerging or vanishing. Although the density of theme clusters contained in the fourth quadrant (Quadrant IV, lower right) is low, it has high centrality, which indicates that its internal structure is loose and its development has not achieved sufficient maturity.

Figure 5.

Figure 5

Strategic diagrams for MRI studies on schizophrenia in three different periods. (A) Explanation of the strategic diagram. (B) Strategic diagram for MRI studies on schizophrenia in 2004–2008. The coordinate values of Cluster 1 are (0.40787, 0.07288), which locates it in Quadrant I. (C) Strategic diagram for MRI studies on schizophrenia in 2009–2013. (D) Strategic diagram for MRI studies on schizophrenia in 2014–2018. The coordinate values of Cluster 2 are (-0.39885, -0.37111), which locates it in Quadrant I. Clusters in each strategic diagram refer to the bi-clustering results presented in Table 3. The size of each single node is proportional to the number of high-frequency major MeSH terms/MeSH subheadings involved in each cluster (Figures 5 A – D).

Social Network Analysis

SNA, as an increasingly applied and rapidly developing method in variety of fields (e.g., psychology, sociology, mathematics, statistics, and others), emphasizes the connectivity and interdependence of elements in a group (29). In this study, to analyze and interpret the theme trends and knowledge structural characteristics of MRI studies of schizophrenia, we employed the “centrality” concept from SNA on the basis of the high-frequency major Mesh terms/MeSH subheadings co-occurrence matrix. Furthermore, to assess the importance of each node, statistical indices including degree, betweenness, and closeness centrality were selected to perform the network analysis. The connotation of each index is explained as follows: (1) Degree centrality is calculated by the number of direct links associated with or connected to one node within the network (30). This index is suitable for evaluating the co-occurrence level among nodes, indicating the importance of one given node to the network. This is evaluated by their degree centrality. (2) Betweenness centrality is calculated by the number of shortest paths between two other nodes that pass through one given node (31). This index can indicate the influence of this node to the network, that is, the higher the betweenness centrality value, the more powerful is this node in controlling other nodes within a network (32). (3) Closeness centrality also can be used as another measure for quantifying the importance of a given node (33). In contrast to betweenness centrality, this index is calculated from the reciprocal of the sum of the lengths of the shortest paths between the node and all other nodes within the network. Therefore, the larger the closeness centrality value of the given node, the closer it is to all the other nodes within the network.

Given that betweenness centrality, as a mediating role, is more applicable to describe the decisive effect within the whole network, we chose it to scale the node sizes. Calculation of the related statistical indices and drawing of the network diagrams were completed using Ucinet 6.0 software (Analytic Technologies Co., Nicholasville, Kentucky, USA), while visualization of the network structure was demonstrated using NetDraw 2.084 software (http://www.analytictech.com/downloadnd.htm).

Results

Distribution Characteristics of Related Publications

In this study, 916, 1,344, and 1,512 literatures were retrieved from the three periods of 2004 to 2008, 2009 to 2013, and 2014 to 2018, respectively, which were then subjected to comparative analysis using the statistical indices of authors, source of countries, and journals. The annual total number of MRI studies on schizophrenia presented an overall growth trend (Figure 1). The top five countries in this research field in the first period, in descending order of production, were the United States, England, Netherlands, Ireland, and Germany, while Netherlands overtook England for the second place in other two periods (Table 1). Additionally, it was clear that the proportion of publications in the U.S., which was the highest in all three periods, has been trending down, while Netherlands and England’s percentage of publication have continuously increased. The top two journals were Schizophrenia Research and Psychiatry Research in the first two periods, while Biological Psychiatry in 2004–2013 was replace by Schizophrenia Bulletin in 2009–2013. These three journals together contained more than 33.54% and 33.65% of the total number of searched publications in this field in the first two periods, respectively. From 2014 to 2018, the top three journals were Schizophrenia Research, Schizophrenia Bulletin, and NeuroImage. Clinical. Furthermore, the journal Schizophrenia Research ranked first in the number of articles published in all three periods, but its proportion of the total number of searched publications declined slightly. In addition, Shenton ME was the greatest contributor to MRI studies on schizophrenia research in the first period, while Calhoun VD contributed the most academic papers in the last two periods.

Figure 1.

Figure 1

The number of publications of MRI studies on schizophrenia in PubMed from 2004 to 2018.

Table 1.

Temporal distribution of publications of MRI studies on schizophrenia in PubMed from 2004 to 2018.

Period Rank Country Top journal Author
Name Publications, n (%) Title Publication, n (%) Name Number of papers
2004- 2008 1 United States 427(44.11%) Schizophrenia research 162(16.71%) Shenton ME 35
2 England 178(18.39%) Psychiatry research 86(8.88%) McCarley RW 34
3 Netherlands 178(18.39%) Biological psychiatry 77(7.95%) Lawrie SM 30
4 Ireland 96(9.92%) NeuroImage 73(7.53%) Johnstone EC 29
5 Germany 42(4.34%) The American journal of psychiatry 67(6.91%) Keshavan MS 26
Total 921(95.15%) 465(47.98%)
2009- 2013 1 United States 574(39.70%) Schizophrenia research 242(16.69%) Calhoun VD 58
2 Netherlands 285(19.71%) Psychiatry research 132(9.10%) Shenton ME 41
3 England 273(18.88%) Schizophrenia bulletin 114(7.86%) Keshavan MS 40
4 Ireland 144(9.96%) NeuroImage 96(6.62%) Kubicki M 37
5 Germany 70(4.84%) Biological psychiatry 61(4.20%) Kahn RS 35
Total 1346(93.09%) 645(44.47%)
2014- 2018 1 United States 573(37.26%) Schizophrenia research 222(14.37%) Calhoun VD 77
2 Netherlands 425(27.63%) Schizophrenia bulletin 125(8.09%) Pearlson GD 36
3 England 311(20.22%) NeuroImage. Clinical 81(5.24%) Andreassen OA 36
4 Ireland 74(4.81%) Psychiatry research. Neuroimaging 63(4.08%) Agartz I 35
5 Germany 45(2.93%) Psychiatry research 62(4.01%) Guo W 34
Total 1428(92.85%) 553(35.79%)

Research Hotspots Identified and Theme Clusters Summarized Based on MeSH Term Clusters

From the searched literature, 26, 34, and 36 high-frequency major MeSH terms/MeSH subheadings were extracted in each period, respectively, and their cumulative frequency percentages were 49.0459, 53.8805, and 52.1285% of the total, and thus could be considered as the research hotspots of MRI studies on schizophrenia in the past three 5-year time periods (Table 2). And, it should be pointed out that in the second period of 2009–2013, the word frequency values of 33rd and 34th major MeSH terms/MeSH subheadings were the same as 33, so we extracted 34 high-frequency MeSH terms.

Table 2.

Distribution of the high-frequency major MeSH terms/MeSH subheadings of MRI studies on schizophrenia in PubMed from 2004 to 2018.

Period Threshold value of high- and low-frequency of MeSH terms Number of high-frequency of MeSH terms Frequency Cumulative frequency
Min Max
2004-2008 26 26 26 327 49.0459%
2009-2013 33 34 33 663 53.8805%
2014-2018 36 36 36 605 52.1285%

The high-frequency MeSH terms in each period can be seen in Figures 24.

According to bi-clustering analysis, 26, 34, and 36 high-frequency major MeSH terms/MeSH subheadings in each period were evenly divided into three clusters (Figures 24). For the results of mountain visualization, Cluster 0 in the first period, Clusters 1 and 2 in the second period, and Clusters 0 and 1 in the third period were marked with red peaks, which represented the most significant results with centralized distribution and low internal standard deviation of the internal similarity within clusters. Furthermore, we have made explicit the relationships among high-frequency major MeSH terms/MeSH subheadings and involved literatures from matrix visualization in each period. The major MeSH terms/MeSH subheadings contained in each cluster are displayed on the right side of the matrix, and the number before them referred to the descending rank of the frequency or proportion of frequency from the included literatures in each period. Moreover, an in-depth understanding of the meaning of the MeSH terms themselves, term-source literatures, as well as the significant representative literatures selected by bi-clustering analysis would be conducive to analyze and summarize the theme of each cluster. At the same time, it would also helpful to further interpret the connotation of the relevant literatures in each cluster.

Figure 2.

Figure 2

Bi-clustering analysis of 26 high-frequency MeSH terms/MeSH subheadings and literatures of MRI studies on schizophrenia in 2004 to 2008. (A) Matrix visualization of bi-clustering of 26 high-frequency major MeSH terms/MeSH subheadings and PubMed unique identifiers of literatures. (B) Mountain visualization of bi-clustering of 26 high-frequency major MeSH terms/MeSH subheadings and literatures.

Figure 4.

Figure 4

Bi-clustering analysis of 36 high-frequency major MeSH terms/MeSH subheadings and literatures of MRI studies on schizophrenia in 2014 to 2018. (A) Matrix visualization of bi-clustering of 36 high-frequency major MeSH terms/MeSH subheadings and PubMed unique identifier of literatures. (B) Mountain visualization of bi-clustering of 36 high-frequency major MeSH terms/MeSH subheadings and literatures.

Figure 3.

Figure 3

Bi-clustering analysis of 34 high-frequency major MeSH terms/MeSH subheadings and literatures of MRI studies on schizophrenia in 2009 to 2013. (A) Matrix visualization of bi-clustering of 34 high-frequency major MeSH terms/MeSH subheadings and PubMed unique identifiers of literatures. (B) Mountain visualization of bi-clustering of 34 high-frequency major MeSH terms/MeSH subheadings and literatures.

Theme Trends of MRI Studies on Schizophrenia

In this study, we plotted strategic diagrams so as to systematically compare similarities and differences of the theme clusters in the three periods and explore the developmental trends of MRI studies on schizophrenia. The number of high-frequency major MeSH terms/MeSH subheadings involved in each cluster can be reflected by the area of the nodes, that is, the greater the number, the larger the area (Figure 5B–D).

Table 3.

Cluster interpretation of high-frequency major MeSH terms/MeSH subheadings of MRI studies on schizophrenia in PubMed from 2004 to 2018.

Period Cluster Content and interpretation of the cluster Rank of MeSH terms Representative literatures (PMID)
2004-2008 Cluster 0 Correlation between brain structural (e.g. cerebral cortex, prefrontal cortex) abnormalities and brain function changes to explore physiopathology mechanism of schizophrenia 1, 3, 4, 5, 7, 8, 12, 17, 21, 23 17085018, 17913465, 16797186, 19042913
Cluster 1 1. Neurodevelopmental abnormalities in patients with schizophrenia 2, 6, 9, 10, 11, 14, 16, 24 18793730, 17166743, 17689500, 16179202
2. Analysis of regional abnormal structural features and influencing factors of the brain
Cluster 2 1. Analysis of metabolism, therapeutic efficacy of antipsychotic agents on brain structure 13, 15, 18, 19, 20, 22, 25, 26 15201569, 17507880, 15520356, 16005383, 15809403
2. Schizophrenia pathology (from the perspective of temporal lobe, prefrontal cortex and anatomy and histology of brain structure)
2009–2013 Cluster 0 Research on the physiopathology mechanism (from the perspective of frontal lobe, temporal lobe, prefrontal cortex, neural pathways) of schizophrenia and the etiology of cognitive disorder and other complications 6, 10, 18, 22, 24, 26, 27, 28, 31 19097861, 20452574, 21868203, 19683896, 22105156
Cluster 1 1. Research on brain structure and function (e.g. hippocampus, nerve fibers, cerebral cortex) and differentiate schizophrenia from bipolar disorder based on MRI 1, 3, 8, 9, 11, 13, 16, 20, 23, 33, 34 24004694, 22832855, 20573561, 21878411, 19042913, 22945617
2. MRI (including DTI) usages, image interpretations
Cluster 2 1. Research on default mode network in schizophrenia patients 2, 4, 5, 7, 12, 14, 15, 17, 19, 21, 25, 29, 30, 32 21095105, 21147518, 19931396, 21277171
2. Schizophrenic psychology (association between anatomical and functional cerebral deficits with related clinical symptoms)
2014–2018 Cluster 0 Research on brain structural and functional abnormality (e.g. prefrontal cortex, nerve net) of patients with schizophrenia, as well as physiopathology mechanism of the disease 1, 4, 12, 14, 15, 18, 19, 23, 27, 31, 32, 34 24306091, 26123450, 28338738, 29527474, 26908926, 28207073
Cluster 1 1. Research on the difference of neurobiological basis between schizophrenia and other mental diseases 2, 6, 10, 13, 16, 20, 21, 22, 24, 26, 29, 33, 35 28347393, 25904725, 25089761, 29257977, 25829144, 25968549
2. Effects of antipsychotics on brain structural changes
Cluster 2 1. Effects of genetic load on brain function of schizophrenia patients 3, 5, 7, 8, 9, 11, 17, 25, 28, 30, 36 27479923, 27375133, 27829096, 29935206, 29247760
2. Identification of schizophrenia biomarkers

“Rank of MeSH terms” represents the number of high-frequency major MeSH terms/MeSH subheadings in each period as shown in Figures 24.

In the first period of 2004–2008, Cluster 0 and Cluster 1 were located in Quadrant I. Cluster 0 represents the correlation between brain structural abnormalities and brain function changes to explore physiopathology mechanism of schizophrenia, while Cluster 1 represented neurodevelopmental abnormalities in patients with schizophrenia and analysis of regional abnormal structural features and influencing factors in the brain. These two clusters were developed and in the core status with adequate centrality and high density. Cluster 2 in Quadrant III represented analysis of metabolism, therapeutic efficacy of antipsychotic agents on brain structure and schizophrenia pathology, which had not matured and were in the beginning stages of research in this field.

Compared with the results of 2004–2008, research on brain structure and function in the 2009–2013 period was still located in Quadrant I and was regarded as a mature and developed research area. However, in contrast to the similar theme cluster contents in the previous period, research in the 2009–2013 period was not only focused on the study of brain structure and function in patients with schizophrenia, but also paid more attention to the differential diagnosis of patients with bipolar disorder or other mental disorders. Furthermore, research on the physiopathology mechanisms of schizophrenia and the etiology of cognitive disorder and other complications, the structure and function of the brain default mode network, as well as schizophrenic psychology were newly developed themes.

In the third period of 2014–2018, theme clusters in Quadrant III, including research on differences in the neurobiological basis between schizophrenia and other mental diseases, were similar to the developed and mature theme contents in the first and second periods, which were identified as peripheral and undeveloped themes in the most recent 5 years. In addition, new emerging theme clusters researching on brain structural and functional abnormality of patients with schizophrenia, as well as physiopathology mechanism of the disease were located in Quadrant II, indicating they were developed but still peripheral research areas. Other emerging theme clusters, including effects of genetic load on brain function of schizophrenia patients, as well as identification of schizophrenia biomarkers, were new main undeveloped themes situated in Quadrant IV, which represented central and undeveloped research topics.

To summarize, these three strategic diagrams clearly revealed the current situation and development tendency of each theme cluster of MRI studies on schizophrenia during three different periods.

Knowledge Structure of MRI Studies on Schizophrenia

In this study, statistical indices of degree, betweenness and closeness centrality were applied to describe the knowledge structure of SNA networks in three different periods (Tables 4 and 5). The three SNAs were plotted on the basis of betweenness centrality to gain insight into the results (Figure 6). As we commented in the figure legends, the size of nodes was proportional to the betweenness centrality of the major MeSH terms/MeSH subheadings, and the thickness of the lines represents the term-term co-occurrence frequency.

Table 4.

Descriptive statistics for centrality measures of MRI studies on schizophrenia from 2004 to 2018.

Period Density Degree Closeness Betweenness
Max Min x¯± S Network centralization Max Min x¯± S Network centralization Max Min x¯± S Network centralization
2004–2008 8.145±15.599 674.00 41.00 203.69 ± 184.44 17.88% 100.00 62.50 79.90 ± 10.10 42.69% 8.42 0.48 3.39 ± 2.38 1.74%
2009–2013 8.080 ± 17.782 1311.00 73.00 266.65 ± 273.88 15.80% 100.00 66.00 80.05 ± 9.82 41.76% 10.61 0.61 4.41 ± 2.95 1.21%
2014-2018 7.062 ± 16.209 1204.00 48.00 247.17 ± 241.62 13.47% 97.22 64.82 81.18 ± 8.76 33.49% 9.38 0.89 4.31 ± 2.33 0.88%

Table 5.

Descriptive statistics for centrality measure about MRI studies on schizophrenia from 2004 to 2018.

Period Rank of MeSH terms High-frequency MeSH terms/MeSH subheadings Centrality Rank of MeSH terms High-frequency MeSH terms/MeSH subheadings Centrality
Degree Betweenness Closeness Degree Betweenness Closeness
2004–2008 3 Magnetic Resonance Imaging 674.000 5.320 89.286 15 Antipsychotic Agents/therapeutic use 99.000 3.174 80.645
1 Schizophrenia/physiopathology 663.000 8.417 100.000 16 Cerebral Cortex/pathology 93.000 2.587 75.758
4 Schizophrenia/diagnosis 461.000 8.417 100.000 14 Brain Mapping 91.000 1.650 71.429
5 Schizophrenic Psychology 429.000 5.313 92.593 21 Diffusion Magnetic Resonance Imaging 86.000 1.927 71.429
2 Schizophrenia/pathology 415.000 7.593 96.154 20 Brain/anatomy & histology 81.000 1.653 73.529
7 Image Processing, Computer-Assisted 389.000 1.736 78.125 24 Image Interpretation, Computer-Assisted/methods 72.000 0.482 62.500
6 Brain/pathology 299.000 3.682 80.645 25 Temporal Lobe/pathology 69.000 2.238 73.529
8 Brain/physiopathology 275.000 5.543 86.207 11 Schizophrenia/complications 69.000 1.530 71.429
9 Schizophrenia/genetics 178.000 7.441 96.154 23 Cerebral Cortex/physiopathology 67.000 1.454 71.429
17 Imaging, Three-Dimensional 162.000 1.246 73.529 19 Magnetic Resonance Imaging/statistics & numerical data 65.000 1.313 71.429
12 Prefrontal Cortex/physiopathology 144.000 3.388 80.645 26 Prefrontal Cortex/pathology 63.000 1.480 75.758
10 Magnetic Resonance Imaging/methods 135.000 4.448 83.333 22 Schizophrenia/epidemiology 55.000 2.312 73.529
13 Schizophrenia/drug therapy 121.000 2.806 80.645 18 Schizophrenia/metabolism 41.000 0.851 67.568
2009– 2013 1 Schizophrenia/pathology 1322.000 10.606 100.000 16 Psychotic Disorders/pathology 140.000 4.133 80.488
2 Schizophrenia/physiopathology 909.000 9.658 97.059 27 Neural Pathways/pathology 127.000 4.210 80.488
4 Schizophrenic Psychology 754.000 10.606 100.000 22 Temporal Lobe/pathology 114.000 3.411 78.571
3 Brain/pathology 700.000 7.333 91.667 25 Neural Pathways/physiopathology 114.000 2.137 71.739
5 Brain/physiopathology 488.000 5.934 84.615 23 Bipolar Disorder/pathology 114.000 1.953 71.739
7 Magnetic Resonance Imaging 447.000 8.232 91.667 28 Cognition Disorders/etiology 113.000 2.103 71.739
6 Brain Mapping 397.000 8.011 91.667 21 Cerebral Cortex/physiopathology 111.000 2.063 71.739
10 Schizophrenia/complications 320.000 6.084 84.615 26 Brain/blood supply 111.000 0.794 67.347
9 Magnetic Resonance Imaging/methods 302.000 6.204 84.615 20 Hippocampus/pathology 104.000 3.953 78.571
8 Schizophrenia/genetics 281.000 9.526 97.059 29 Emotions/physiology 102.000 1.975 71.739
12 Schizophrenia/diagnosis 246.000 7.139 89.189 34 Image Interpretation, Computer-Assisted/methods 100.000 1.012 67.347
11 Cerebral Cortex/pathology 244.000 4.293 82.500 30 Brain Mapping/methods 98.000 2.873 75.000
19 Image Processing, Computer-Assisted 204.000 3.886 78.571 24 Prefrontal Cortex/pathology 94.000 0.607 66.000
13 Nerve Fibers, Myelinated/pathology 200.000 5.405 84.615 15 Schizophrenia/drug therapy 91.000 2.404 75.000
17 Nerve Net/physiopathology 172.000 1.468 70.213 31 Frontal Lobe/pathology 86.000 3.229 76.744
14 Prefrontal Cortex/physiopathology 155.000 2.383 71.739 33 Diffusion Tensor Imaging/methods 85.000 0.917 68.750
18 Memory, Short-Term/physiology 148.000 4.309 78.571 32 Antipsychotic Agents/therapeutic use 73.000 1.154 70.213
2014- 2018 1 Schizophrenia/physiopathology 1240.000 7.924 97.222 13 Schizophrenia/complications 166.000 7.320 89.744
2 Schizophrenia/pathology 945.000 8.434 97.222 21 Cerebral Cortex/pathology 155.000 4.272 79.545
4 Brain/physiopathology 577.000 3.869 83.333 16 Schizophrenia/drug therapy 154.000 3.862 81.395
3 Schizophrenia/diagnostic imaging 514.000 7.642 94.595 24 Bipolar Disorder/pathology 131.000 0.889 64.815
5 Schizophrenic Psychology 466.000 7.722 94.595 23 Brain Mapping/methods 129.000 4.990 83.333
6 Brain/pathology 407.000 5.881 85.366 17 Schizophrenia/diagnosis 126.000 5.120 83.333
7 Magnetic Resonance Imaging/methods 360.000 9.382 97.222 34 Bipolar Disorder/physiopathology 117.000 1.391 70.000
9 Brain/diagnostic imaging 279.000 2.225 76.087 27 Memory, Short-Term/physiology 113.000 1.535 71.429
10 White Matter/pathology 262.000 5.741 87.500 25 Brain Mapping 111.000 4.194 79.545
14 Nerve Net/physiopathology 240.000 4.592 83.333 30 Psychotic Disorders/diagnostic imaging 111.000 3.946 81.395
15 Psychotic Disorders/physiopathology 237.000 5.823 89.744 28 White Matter/diagnostic imaging 108.000 2.059 72.917
8 Schizophrenia/genetics 213.000 7.621 92.105 29 Diffusion Tensor Imaging/methods 107.000 4.112 74.468
11 Magnetic Resonance Imaging 205.000 7.086 89.744 26 Antipsychotic Agents/therapeutic use 101.000 2.463 72.917
12 Prefrontal Cortex/physiopathology 198.000 2.618 76.087 32 Neural Pathways/physiopathology 99.000 1.663 72.917
19 Connectome/methods 194.000 3.040 79.545 31 Emotions/physiology 93.000 2.463 76.087
18 Cerebral Cortex/physiopathology 182.000 2.482 77.778 35 Prefrontal Cortex/pathology 88.000 3.268 76.087
22 Psychotic Disorders/pathology 176.000 2.386 72.917 33 Hippocampus/pathology 78.000 1.446 70.000
20 Gray Matter/pathology 168.000 4.280 79.545 36 Schizophrenia/metabolism 48.000 1.257 68.627

“Rank of MeSH terms” represents the number of high-frequency major MeSH terms/MeSH subheadings in each period as shown in Figures 24.

Figure 6.

Figure 6

SNA for high-frequency major MeSH terms/MeSH subheadings applied to MRI studies on schizophrenia. (A) SNA for 26 high-frequency major MeSH terms/MeSH subheadings in 2004–2008. (B) SNA for 34 high-frequency major MeSH terms/MeSH subheadings in 2009–2013. (C) SNA for 36 high-frequency major MeSH terms/MeSH subheadings in 2014–2018. The size of the nodes and the thickness of the lines within the networks represent centrality of MeSH terms and the co-occurrence frequency of MeSH terms pairs, respectively. Red icons (Inline graphic): Node with the highest betweenness centrality. Circle icons: Nodes highly co-occurred with other nodes since the period of 2004–2008 (Inline graphic), 2009–2013 (Inline graphic) and 2014–2018 (Inline graphic), respectively (Figure 6A–C). Box icons: Emerging nodes in 2004–2008 (Inline graphic), 2009–2013 (Inline graphic) and 2014–2018(Inline graphic), respectively.

In the period of 2004–2008, eight major MeSH terms/MeSH subheadings were shown to have a high degree centrality (greater than the mean value of 203.69, Table 4) within the network of MRI studies on schizophrenia. As can be seen in Table 5, Magnetic Resonance Imaging (674.000) and Schizophrenia/physiopathology (663.000) had higher degree centrality among the eight high-frequency major MeSH term/MeSH subheadings and showed a larger gap between the others. Furthermore, Table 4 also shows that the top two betweenness centrality values listed in Table 5 are the same (8.417), which meant that the two major MeSH terms/MeSH subheadings (Schizophrenia/physiopathology, Schizophrenia/diagnosis) had the strongest mediating effect within the network of the first period. Additionally, both terms had the highest closeness values of 100.000, indicating that they had a tight connection with the other nodes. As shown in Table 5, another seven major MeSH terms/MeSH subheadings had high betweenness values (greater than the mean value of 3.39, Table 4), which suggested that these MeSH terms also played a critical mediating role within the network. In addition, according to Figure 6A, the total number of new emerging hotspots in this period was 12, including Magnetic Resonance Imaging/statistics & numerical data, Schizophrenia/epidemiology, Brain Mapping, Brain/anatomy & histology, Schizophrenia/complications, Schizophrenia/metabolism, Diffusion Magnetic Resonance Imaging, Imaging, Three-Dimensional, Cerebral Cortex/pathology, Imaging Interpretation, Computer-Assisted/methods, as well as Cerebral Cortex/physiopathology, which were located on the edge of the network.

Compared with the SNA of the first period, another four new major MeSH terms/MeSH subheadings (Table 5 and Figure 6B), including Brain Mapping, Schizophrenia/complications, Magnetic Resonance Imaging/methods and Schizophrenia/genetics were added to the nodes with high degree centrality in the second period of 2009–2013. Meanwhile, in addition to Brain Mapping and Schizophrenia/complications, another two MeSH terms (Nerve Net/physiopathology and Memory, Short-Term/physiology) were added to the nodes with high betweenness centrality (greater than the mean value of 4.41, Tables 4 and 5). Furthermore, the MeSH terms Schizophrenia/pathology and Schizophrenic Psychology had the highest betweenness centrality values (10.606) and the highest closeness centrality values (100.00) (Table 5). According to Figure 6B, another 12 new emerging nodes were located at the edge of the network, including Brain Mapping/methods, Neural Pathways/physiopathology, Emotions/physiology, Nerve Net/physiopathology, Prefrontal Cortex/physiopathology, Antipsychotic Agents/therapeutic use, Brain/blood supply, Prefrontal Cortex/pathology, Cognition Disorders/etiology, Hippocampus/pathology, Bipolar Disorder/pathology, and Diffusion Tensor Imaging/methods, identifying them as emerging hotspots of MRI studies on schizophrenia in 2009–2013.

In the SNA of 2014–2018, five new major MeSH terms/MeSH subheadings were added to the nodes (Figure 6C), including Schizophrenia/diagnostic imaging, White Matter/pathology, Nerve Net/physiopathology, Psychotic Disorders/physiopathology, Brain Mapping/methods, which were characterized by high betweenness values (greater than the mean value of 4.31, Table 4). Compared with the SNA of 2009–2013 (Figure 6B), a total of six new emerging nodes, including Brain/diagnostic imaging, Bipolar Disorder/physiopathology, Memory, Short-Term/physiology, Psychotic Disorder/pathology, Prefrontal Cortex/physiopathology, and White Matter/diagnostic imaging, were considered as emerging hotspots of MRI studies on schizophrenia in the third period of 2014–2018 (Figure 6C).

Discussion

The human brain is a complex, efficient, and organic system with nearly 100 billion neurons, but during its process of development, a range of genetic, infectious, stress, family, and social environment factors can cause structural and functional abnormalities (34). Schizophrenia has been recognized as the most important brain degeneration disease treated by psychiatrists. Neuroimaging studies have shown that mental disorders can lead to structural and functional changes in brain regions (35, 36), and the structural changes of brain regions are also important risk factors affecting the prodromal stage of schizophrenia (37, 38). The present study evaluated MRI studies on schizophrenia in recent decades by exploring bibliometrics to reach the conclusion that publication of MRI studies on schizophrenia showed an increasing trend in the last 15 years. However, after in-depth analysis, we observed that growth of the third period became slower than the second, but the number of papers published in 2015 is the largest, showing the peak in three curves. In addition, based on the results of the strategic diagram, we observed that contents of theme clusters in each quadrant have changed to some extend so that we could have a preliminary understanding of the theme trends from 2004 to 2018.

In the first period (2004–2008), theme Cluster 0 and Cluster 1 were located in Quadrant I, representing well-developed and mature topics. From the literature analysis, we found that previous research clarified the relationship between brain structural changes and functional abnormalities and analyzed the structural deficit in the corticothalamic system (39), anatomical changes in the frontal-temporal circuit and functional alterations in the prefrontal cortex (40) for the purpose of exploring the etiology and physiopathology of schizophrenia. Furthermore, the structural parts of abnormal brain regions that led to dysfunction and perceived sources of information were identified and positioned (41).

Another theme (Cluster 2) located in Quadrant I. indicated that research on the analysis of metabolism, therapeutic efficacy of antipsychotic agents on brain structure and schizophrenia pathology was immature and needed further study. Previous reports had suggested that after controlling for confounding factors such as sex and age, antipsychotics could alleviate or treat clinical symptoms by altering brain structure (42, 43), but more recent research has found that first-generation antipsychotic drugs may increase oxidative stress and damage cerebral function (44); therefore, whether antipsychotic agents have a protective or destructive effect on brain structure has not been consistently shown. Moreover, numerous studies have demonstrated that almost all cortical and subcortical structures in schizophrenia patients showed morphological abnormalities, including changes in the volume of brain structures such as the whole brain, temporal lobe, amygdala and hippocampus (4547). Meantime, Fornito, et al. also suggested that impaired brain network connectivity is the pathophysiological basis for diverse clinical symptoms and cognitive impairment of schizophrenia (48). As a result, it is difficult to identify which parts of a brain region that are structurally and functionally abnormal directly contribute to schizophrenia. Therefore, it will be a long process and difficult project to explore the pathological mechanisms of schizophrenia through MRI studies.

During the second period of 2009–2013, partial theme contents of Cluster 1 (research on brain structure and function) were still located in Quadrant I, indicating that researchers kept on paying close attention to the related research topic. With the exception of in-depth studies on nerve fibers, hippocampus, and cerebral cortex (49, 50), good progress has been made in the use of brain imaging to distinguish between schizophrenia and bipolar disorder (51, 52). Moreover, researchers have acquired better understanding of the use of various MRI techniques, their analysis, and interpretation of results (53, 54). In addition, we determined that research on the pathological mechanism of schizophrenia (partial theme contents of Cluster 0, located in Quadrant III) has not yet been fully elucidated and remains as an undeveloped theme. As for the new theme cluster schizophrenia psychology, researchers are dedicated to identifying the basis for the structural and functional activities of brains that cause abnormal psychological symptoms (e.g., emotional withdrawal) in patients with schizophrenia (55, 56). However, due to the diversity of abnormal psychological symptoms in patients and the complicated influencing factors (e.g., course of disease and medication), this field needs further development. Another new theme cluster is brain default mode network (DMN), in which brain network studies have shown changes in the default network functional connectivity in schizophrenia. While results in this area are inconsistent, most studies have shown increased DMN functional connectivity in schizophrenia, as well as weaken functional connections in the prefrontal cortex (57, 58). Nevertheless, taking antipsychotics and changes in psychiatric symptoms can influence resting brain networks, and the intrinsic relationship between genes and DMN have gradually become noteworthy academic issues in recent years (59, 60).

In the third period of 2014–2018, Cluster 1, whose theme contents involve research on differences in the neurobiological basis of schizophrenia and other mental diseases and include studies of the effects of antipsychotics on brain structural changes, was located in Quadrant III. The theme of differential diagnosis of schizophrenia and other mental disorder (e.g., bipolar disorder, schizoaffective disorder), which was originally in Quadrant Iin the second period (2009–2013), is now situated in Quadrant III during the third period (2014-2018). Based on MRI techniques, researchers have studied the similarities and differences in brain structure among patients with schizophrenia and bipolar disorder, such as the two major psychotic disorder have a shared white-matter dysconnectivity in callosal, paralimbic, and fronto-occipital regions (61), but volume reductions in several brain regions of schizophrenic patients, such as the medial frontal cortex, parts of the temporal lobe cortex, the insula and hippocampus cannot be observed in bipolar patients (62). And they also have identified the risk alleles associated with the disease to facilitate more accurate identification and diagnosis (63). Relevant research needs to be further developed and improved.

In addition, as mentioned above, reports about the use of antipsychotics to prevent the progression of brain damage are as yet inconsistent. Numerous studies have found that changes in brain imaging occurred at an early stage in schizophrenia, while structural and functional abnormalities in brain regions caused by grey and white matter volume reductions and anomalous connections, became more prominent with the progression of the condition. But Emsley et al. argued that the brain volume reductions are not directly associated with antipsychotic treatment during the first year of medication, and decrease in brain volume may have more to do with neurotoxicity of drugs than with the therapeutic effect (64). However, due to the differences in research facilities and measuring methods, conclusions are still controversial because abnormal brain regions in various studies do not completely overlap. It remains to be seen whether our next study should take steps to repair brain damage, or whether it should delay, prevent, or interfere with the continued damage to brain structure caused by antipsychotics.

Finally, we can also conclude that the MeSH terms Schizophrenia/physiopathology, Schizophrenia/pathology, and Schizophrenia Psychology have higher or the highest values of betweenness centrality, implying that they have the largest number of direct connections with other nodes, as well as being situated at the core position within the networks. In other words, research on the pathological and physio-pathological mechanisms of schizophrenia, as well as analysis of abnormal psychological and behavioral symptoms from the perspective of brain imaging, are significant and potentially important academic issues in this research field. In addition, the new emerging hotspots in these three periods should be viewed as a guide to finding new directions for research.

Conclusion

The main finding of this study was that MRI studies on schizophrenia have been an issue of general concern, but the progress (e.g. pathogenesis of schizophrenia) is relatively slow in recent years. Further research is necessary to investigate the undeveloped, immature, and emerging hotspots and theme clusters mentioned above so as to provide medical staff, scientific researchers, and frontline educators with new directions in the field of MRI studies on schizophrenia.

Limitation

There are several limitations to consider in the current study. To better present results, years were selected as the time unit to divide time periods and complete statistics. However, the complete data of 2019 has not yet been obtained, so the literature published in this year was not included. In addition, this study only included journals articles, so some research hotspots might have been omitted due to the exclusion of conference papers, reviews, and other types of literature. In addition, there are certain limitations in the scope of the PubMed database collection and in the indexing of MeSH terms, so that literature retrieval based on MeSH terms may miss some publications. Furthermore, this study selected the index of major MeSH terms/MeSH subheadings to extract high-frequency MeSH terms, and we cannot completely exclude the possibility that other low-frequency MeSH terms may become hotspots of research in the future. Finally, the data source only selects the published literatures, which may lead to publication bias.

Author Contributions

GZ designed and corrected the paper. LD wrote the paper.

Funding

This work was supported by grants from the Major Project of the Department of Science & Technology of Liaoning Province (2019JH8/10300019).

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  • 1. Hor K, Taylor M. Suicide and schizophrenia: a systematic review of rates and risk factors. J Psychopharmacol (2010) 24:81–90. 10.1177/1359786810385490 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Buckley PF, Miller BJ, Lehrer DS, Castle DJ. Psychiatric comorbidities and schizophrenia. Schizophr Bull (2009) 35:383–402. 10.1093/schbul/sbn135 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Wieronska JM, Zorn SH, Doller D, Pilc A. Metabotropic glutamate receptors as targets for new antipsychotic drugs: historical perspective and critical comparative assessment. Pharmacol Ther (2016) 157:10–27. 10.1016/j.pharmthera.2015.10.007 [DOI] [PubMed] [Google Scholar]
  • 4. McGrath J, Saha S, Welham J, El Saadi O, MacCauley C, Chant D. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med (2004) 2:13. 10.1186/1741-7015-2-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet (2017) 390:1211–59. 10.1016/S0140-6736(17)32154-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Sandstrom A, Sahiti Q, Pavlova B, Uher R. Offspring of parents with schizophrenia, bipolar disorder, and depression: a review of familial high-risk and molecular genetics studies. Psychiatr Genet (2019) 29:160–9. 10.1097/YPG.0000000000000240 [DOI] [PubMed] [Google Scholar]
  • 7. Hameed MA, Lewis AJ. Offspring of parents with schizophrenia: a systematic review of developmental features across childhood. Harv Rev Psychiatry (2016) 24:104–17. 10.1097/HRP.0000000000000076 [DOI] [PubMed] [Google Scholar]
  • 8. van Os J, Kenis G, Rutten BP. The environment and schizophrenia. Nature (2010) 468:203–12. 10.1038/nature09563 [DOI] [PubMed] [Google Scholar]
  • 9. Weinberger DR. Future of days past: neurodevelopment and schizophrenia. Schizophr Bull (2017) 43:1164–8. 10.1093/schbul/sbx118 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (panss) for schizophrenia. Schizophr Bull (1987) 13:261–76. 10.1093/schbul/13.2.261 [DOI] [PubMed] [Google Scholar]
  • 11. Kaneko G, Sanganahalli BG, Groman SM, Wang H, Coman D, Rao J, et al. Hypofrontality and posterior hyperactivity in early schizophrenia: Imaging and behavior in a preclinical model. Biol Pychiatry (2017) 81:503–13. 10.1016/j.biopsych.2016.05.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Gilmore JH, Smith LC, Wolfe HM, Hertzberg BS, Smith JK, Chescheir NC, et al. Prenatal mild ventriculomegaly predicts abnormal development of the neonatal brain. Biol Psychiatry (2008) 64:1069–76. 10.1016/j.biopsych.2008.07.031 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Li G, Wang L, Shi F, Lyall AE, Ahn M, Peng Z, et al. Cortical thickness and surface area in neonates at high risk for schizophrenia. Brain Struct Funct (2016) 221:447–61. 10.1007/s00429-014-0917-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Koike S. Clinical status and outcome biomarkers in schizophrenia: a review for near-infrared spectroscopy studies. Seishin Shinkeigaku Zasshi (2013) 115:863–73. [PubMed] [Google Scholar]
  • 15. Szulc A, Galińska B, Tarasów E, Kubas B, Dzienis W, Konarzewska B, et al. N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study. Med Sci Monit (2007) 13:17–22. [PubMed] [Google Scholar]
  • 16. Jacobi W, Winkler H. Encephalographische studien an schizophrenen. Archiv Für Psychiatr Und Nervenkrankheiten (1927) 81:299–332. 10.1007/BF01825649 [DOI] [Google Scholar]
  • 17. Johnstone EC, Crow TJ, Frith CD, Husband J, Kreel L. Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet (1976) 2:924–6. 10.1016/S0140-6736(76)90890-4 [DOI] [PubMed] [Google Scholar]
  • 18. Smith RC, Calderon M, Ravichandran GK, Largen J, Vroulis G, Shvartsburd A, et al. Nuclear magnetic resonance in schizophrenia: A preliminary study. Psychiatry Res (1984) 12:137–47. 10.1016/0165-1781(84)90013-1 [DOI] [PubMed] [Google Scholar]
  • 19. Johnson MH, Cohen J, Grudzinskas G. The uses and abuses of bibliometrics. Reprod BioMed Online (2012) 24:485–6. 10.1016/j.rbmo.2012.03.007 [DOI] [PubMed] [Google Scholar]
  • 20. Yao Q, Chen K, Yao L, Lyu PH, Yang TA, Luo F, et al. Scientometric trends and knowledge maps of global health systems research. Health Res Policy Syst (2014) 12:26. 10.1186/1478-4505-12-26 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Hirsch JE. An index to quantify an individual’s scientific research output. Proc Natl Acad Sci U S A. (2005) 102:16569–72. 10.1073/pnas.0507655102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Guan JC, Gao X. Exploring the h-index at patent level. J Am Soc Inf Sci Technol (2008) 60:35–40. 10.1002/asi.20954 [DOI] [Google Scholar]
  • 23. Braun T, Glänzel W, Schubert A. A Hirsch-type index for journals. Scientometrics (2006) 69:169–73. 10.1007/s11192-006-0147-4 [DOI] [Google Scholar]
  • 24. Raan AFJV. Comparison of the Hirsch-index with standard bibliometric indicators and with peer judgment for 147 chemistry research groups. Scientometrics (2006) 67:491–502. 10.1556/Scient.67.2006.3.10 [DOI] [Google Scholar]
  • 25. Li F, Li M, Guan P, Ma S, Cui L. Mapping publication trends and identifying hot spots of research on Internet health information seeking behavior: a quantitative and co-word biclustering analysis. J Med Internet Res (2015) 17:e81. 10.2196/jmir.3326 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Hartigan JA. Direct clustering of a data matrix. Publ Am Stat Assoc (1972) 67:7. 10.1080/01621459.1972.10481214 [DOI] [Google Scholar]
  • 27. Law J, Bauin S, Courtial JP, Whittaker J. Policy and the mapping of scientific change: a co-word analysis of research into environmental acidification. Scientometrics (1988) 14:251–64. 10.1007/BF02020078 [DOI] [Google Scholar]
  • 28. Viedma-Del-Jesus MI, Perakakis P, Muñoz M, López-Herrera AG, Vila J. Sketching the first 45 years of the journal psychophysiology (1964-2008): a co-word-based analysis. Psychophysiology (2011) 48:1029–36. 10.1111/j.1469-8986.2011.01171.x [DOI] [PubMed] [Google Scholar]
  • 29. Parnell JM, Robinson JC. Social network analysis: presenting an underused method for nursing research. J Adv Nurs (2018) 74:1310–8. 10.1111/jan.13541 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Guillon Q, Afzali MH, Rogé B, Baduel S, Kruck J, Hadjikhani N. The importance of networking in autism gaze analysis. PloS One (2015) 10:e0141191. 10.1371/journal.pone.0141191 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. APA Brede M Networks—an introduction. mark e. j. newman. (2010, oxford university press.). Artif Life (2012) 18:241–:2. 10.1162/artl_r_00062 [DOI] [Google Scholar]
  • 32. Freeman LC. A set of measures of centrality based on betweenness. Sociometry (1977) 40:35–41. 10.2307/3033543 [DOI] [Google Scholar]
  • 33. Sadria M, Karimi S, Layton AT. Network centrality analysis of eye-gaze data in autism spectrum disorder. Comput Biol Med (2019) 111:103332. 10.1016/j.compbiomed.2019.103332 [DOI] [PubMed] [Google Scholar]
  • 34. Liang X. Human connectome: structural and functional brain networks. Chin J (2010) 55:1565. 10.1360/972009-2150 [DOI] [Google Scholar]
  • 35. Fusar-Poli P. Voxel-wise meta-analysis of fMRI studies in patients at clinical high risk for psychosis. J Psychiatry Neurosci (2012) 37:106–12. 10.1503/jpn.110021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Smieskova R, Fusar-Poli P, Allen P, Bendfeldt K, Stieglitz RD, Drewe J, et al. Neuroimaging predictors of transition to psychosis–a systematic review and meta-analysis. Neurosci Biobehav Rev (2010) 34:1207–22. 10.1016/j.neubiorev.2010.01.016 [DOI] [PubMed] [Google Scholar]
  • 37. Nenadic I, Dietzek M, Schönfeld N, Lorenz C, Gussew A, Reichenbach JR, et al. Brain structure in people at ultra-high risk of psychosis, patients with first-episode schizophrenia, and healthy controls: a VBM study. Schizophr Res (2015) 161:169–76. 10.1016/j.schres.2014.10.041 [DOI] [PubMed] [Google Scholar]
  • 38. Lesh TA, Careaga M, Rose DR, McAllister AK, Van de Water J, Carter CS, et al. Cytokine alterations in first-episode schizophrenia and bipolar disorder: Relationships to brain structure and symptoms. J Neuroinflamm (2018) 15:165. 10.1186/s12974-018-1197-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Kim JJ, Kim DJ, Kim TG, Seok JH, Chun JW, Oh MK, et al. Volumetric abnormalities in connectivity-based subregions of the thalamus in patients with chronic schizophrenia. Schizophr Res (2007) 97:226–35. 10.1016/j.schres.2007.09.007 [DOI] [PubMed] [Google Scholar]
  • 40. Schlösser RG, Nenadic I, Wagner G, Güllmar D, von Consbruch K, Köhler S, et al. White matter abnormalities and brain activation in schizophrenia: a combined DTI and fMRI study. Schizophr Res (2007) 89:1–11. 10.1016/j.schres.2006.09.007 [DOI] [PubMed] [Google Scholar]
  • 41. Simons JS, Davis SW, Gilbert SJ, Frith CD, Burgess PW. Discriminating imagined from perceived information engages brain areas implicated in schizophrenia. Neuroimage (2006) 32:696–703. 10.1016/j.neuroimage.2006.04.209 [DOI] [PubMed] [Google Scholar]
  • 42. Molina V, Sanz J, Benito C, Palomo T. Direct association between orbitofrontal atrophy and the response of psychotic symptoms to olanzapine in schizophrenia. Int Clin Psychopharmacol (2004) 19:221–8. 10.1097/01.yic.0000125753.01426.d7 [DOI] [PubMed] [Google Scholar]
  • 43. van Haren NE, Hulshoff Pol HE, Schnack HG, Cahn W, Mandl RC, Collins DL, et al. Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study. Neuropsychopharmacology (2007) 32:2057–66. 10.1038/sj.npp.1301347 [DOI] [PubMed] [Google Scholar]
  • 44. Bai ZL, Li XS, Chen GY, Du Y, Wei ZX, Chen X, et al. Serum oxidative stress marker levels in unmedicated and medicated patients with schizophrenia. J Mol Neurosci (2018) 66:428–36. 10.1007/s12031-018-1165-4 [DOI] [PubMed] [Google Scholar]
  • 45. James AC, James S, Smith DM, Javaloyes A. Cerebellar, prefrontal cortex, and thalamic volumes over two time points in adolescent-onset schizophrenia. Am J Psychiatry (2004) 161:1023–9. 10.1176/appi.ajp.161.6.1023 [DOI] [PubMed] [Google Scholar]
  • 46. Staal WG, Hulshoff Pol HE, Schnack HG, van Haren NE, Seifert N, Kahn RS. Structural brain abnormalities in chronic schizophrenia at the extremes of the outcome spectrum. Am J Psychiatry (2001) 158:1140–2. 10.1176/appi.ajp.158.7.1140 [DOI] [PubMed] [Google Scholar]
  • 47. Buchsbau MS, Friedman J, Chu KW, Newmark R, Schneiderman JS, Torosjan Y, et al. Diffusion tensor imaging in schizophrenia. Biol Psychiatry (2005) 58:921–9. 10.1016/j.schres.2007.10.009 [DOI] [PubMed] [Google Scholar]
  • 48. Fornito A, Yoon J, Zalesky A, Bullmore ET, Carter CS. General and specific functional connectivity disturbances in first-episode schizophrenia during cognitive control performance. Biol Psychiatry (2011) 70:64–72. 10.1016/j.biopsych.2011.02.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Gogtay N, Hua X, Stidd R, Boyle CP, Lee S, Weisinger B, et al. Delayed white matter growth trajectory in young nonpsychotic siblings of patients with childhood-onset schizophrenia. Arch Gen Psychiatry (2012) 69:875–84. 10.1001/archgenpsychiatry.2011.2084 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Mandl RC, Schnack HG, Luigjes J, van den Heuvel MP, Cahn W, Kahn RS, et al. Tract-based analysis of magnetization transfer ratio and diffusion tensor imaging of the frontal and frontotemporal connections in schizophrenia. Schizophr Bull (2010) 36:778–87. 10.1093/schbul/sbn161 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Schnack HG, Nieuwenhuis M, van Haren NE, Abramovic L, Scheewe TW, Brouwer RM, et al. Can structural MRI aid in clinical classification? A machine learning study in two independent samples of patients with schizophrenia, bipolar disorder and healthy subjects. Neuroimage (2014) 84:299–306. 10.1016/j.neuroimage.2013.08.053 [DOI] [PubMed] [Google Scholar]
  • 52. Morris RW, Sparks A, Mitchell PB, Weickert CS, Green MJ. Lack of cortico-limbic coupling in bipolar disorder and schizophrenia during emotion regulation. Transl Psychiatry (2012) 2:e90. 10.1038/tp.2012.16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Voineskos AN, O’Donnell LJ, Lobaugh NJ, Markant D, Ameis SH, Niethammer M, et al. Quantitative examination of a novel clustering method using magnetic resonance diffusion tensor tractography. Neuroimage (2009) 45:370–6. 10.1016/j.neuroimage.2008.12.028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Venkataraman A, Rathi Y, Kubicki M, Westin CF, Golland P. Joint modeling of anatomical and functional connectivity for population studies. IEEE Trans Med Imaging (2012) 31:164–82. 10.1109/TMI.2011.2166083 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Kumari V, Fannon D, Ffytche DH, Raveendran V, Antonova E, Premkumar P, et al. Functional MRI of verbal self-monitoring in schizophrenia: performance and illness-specific effects. Schizophr Bull (2010) 36:740–55. 10.1093/schbul/sbn148 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Herold R, Feldmann A, Simon M, Tényi T, Kövér F, Nagy F, et al. Regional gray matter reduction and theory of mind deficit in the early phase of schizophrenia: a voxel-based morphometric study. Acta Psychiatr Scand (2009) 119:199–208. 10.1111/j.1600-0447.2008.01297.x [DOI] [PubMed] [Google Scholar]
  • 57. Greicius MD, Supekar K, Menon V, Dougherty RF. Resting-state functional connectivity reflects structural connectivity in the default mode network. Cereb Cortex (2009) 19:72–8. 10.1093/cercor/bhn059 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Shen H, Wang L, Liu Y, Hu D. Discriminative analysis of resting-state functional connectivity patterns of schizophrenia using low dimensional embedding of fMRI. Neuroimage (2010) 49:3110–21. 10.1016/j.neuroimage.2009.11.011 [DOI] [PubMed] [Google Scholar]
  • 59. Zong X, Hu M, Pantazatos SP, Mann JJ, Wang G, Liao Y, et al. A dissociation in effects of risperidone monotherapy on functional and anatomical connectivity within the default mode network. Schizophr Bull (2018) 45:1309-18. 10.1093/schbul/sby175 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Richiardi J, Altmann A, Milazzo AC, Chang C, Chakravarty MM, Banaschewski T, et al. BRAIN NETWORKS. Correlated gene expression supports synchronous activity in brain networks. Science (2015) 348:1241–4. 10.1126/science.1255905 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61. Kumar J, Iwabuchi S, Oowise S, Balain V, Palaniyappan L, Liddle PF. Shared white-matter dysconnectivity in schizophrenia and bipolar disorder with psychosis. Psychol Med (2015) 45:759–70. 10.1017/S0033291714001810 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Amann BL, Canales-Rodríguez EJ, Madre M, Radua J, Monte G, Alonso-Lana S, et al. Brain structural changes in schizoaffective disorder compared to schizophrenia and bipolar disorder. Acta Psychiatr Scand (2016) 133:23–33. 10.1111/acps.12440 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63. Tecelão D, Mendes A, Martins D, Bramon E, Toulopoulou T, Kravariti E, et al. The impact of psychosis genome-wide associated ZNF804A variation on verbal fluency connectivity. J Psychiatr Res (2018) 98:17–21. 10.1016/j.jpsychires.2017.12.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64. Emsley R, Asmal L, du Plessis S, Chiliza B, Phahladira L, Kilian S. Brain volume changes over the first year of treatment in schizophrenia: relationships to antipsychotic treatment. Psycholl Med (2017) 47:2187–96. 10.1017/S0033291717000642 [DOI] [PubMed] [Google Scholar]

Articles from Frontiers in Psychiatry are provided here courtesy of Frontiers Media SA

RESOURCES